KP Tissue Inc. (TSE:KPT - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$11.68 and traded as high as C$12.93. KP Tissue shares last traded at C$12.80, with a volume of 5,491 shares changing hands.
Wall Street Analyst Weigh In
A number of analysts have recently commented on KPT shares. TD upped their target price on shares of KP Tissue from C$12.00 to C$14.00 and gave the stock a "hold" rating in a research report on Tuesday, July 14th. Desjardins lifted their price target on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a "hold" rating in a research report on Friday, May 15th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, KP Tissue presently has a consensus rating of "Hold" and an average price target of C$12.12.
Read Our Latest Research Report on KPT
KP Tissue Trading Down 0.8%
The company has a market cap of C$128.36 million, a PE ratio of 14.22, a P/E/G ratio of -0.88 and a beta of 0.53. The firm has a 50 day moving average of C$13.02 and a two-hundred day moving average of C$11.68.
KP Tissue (TSE:KPT - Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported C$0.22 earnings per share (EPS) for the quarter. On average, research analysts forecast that KP Tissue Inc. will post 0.4398964 EPS for the current year.
KP Tissue Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 15th were issued a dividend of $0.21 per share. The ex-dividend date was Tuesday, June 30th. This represents a $0.84 annualized dividend and a dividend yield of 6.6%. KP Tissue's dividend payout ratio (DPR) is presently 80.00%.
Insider Activity
In related news, Director David A. Spraley sold 3,668 shares of the company's stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total value of C$48,784.40. Following the transaction, the director owned 15,712 shares in the company, valued at C$208,969.60. The trade was a 18.93% decrease in their position. Over the last ninety days, insiders sold 6,668 shares of company stock valued at $87,644. 0.14% of the stock is owned by insiders.
About KP Tissue
(
Get Free Report)
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.